Two Onc Docs cover image

Metastatic Prostate Cancer 2023 UPDATE

Two Onc Docs

00:00

Genetic Testing and Treatment Options for Prostate Cancer in 2023

Exploration of genetic testing significance in stage 4 prostate cancer, focusing on Drimline testing standards and treatment strategies based on mutations such as BRCA2, utilizing PARP inhibitors and combination therapies for personalized care.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app